Emyria Past Earnings Performance
Past criteria checks 0/6
Emyria's earnings have been declining at an average annual rate of -22.7%, while the Pharmaceuticals industry saw earnings growing at 35.1% annually. Revenues have been growing at an average rate of 20.7% per year.
Key information
-22.7%
Earnings growth rate
-3.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 31.2% |
| Revenue growth rate | 20.7% |
| Return on equity | -472.3% |
| Net Margin | -520.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Emyria makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -11 | 2 | 0 |
| 31 Mar 24 | 2 | -12 | 2 | 0 |
| 31 Dec 23 | 2 | -12 | 2 | 0 |
| 30 Sep 23 | 2 | -9 | 2 | 0 |
| 30 Jun 23 | 2 | -5 | 2 | 0 |
| 31 Mar 23 | 2 | -6 | 2 | 1 |
| 31 Dec 22 | 2 | -8 | 2 | 2 |
| 30 Sep 22 | 2 | -7 | 3 | 2 |
| 30 Jun 22 | 2 | -7 | 3 | 1 |
| 31 Mar 22 | 2 | -7 | 3 | 1 |
| 31 Dec 21 | 2 | -6 | 3 | 1 |
| 30 Sep 21 | 2 | -6 | 2 | 1 |
| 30 Jun 21 | 2 | -5 | 2 | 1 |
| 31 Mar 21 | 2 | -5 | 2 | 1 |
| 31 Dec 20 | 2 | -5 | 1 | 1 |
| 30 Sep 20 | 1 | -5 | 2 | 1 |
| 30 Jun 20 | 1 | -5 | 2 | 1 |
| 31 Mar 20 | 1 | -5 | 2 | 1 |
| 31 Dec 19 | 1 | -4 | 2 | 0 |
| 30 Sep 19 | 0 | -3 | 2 | 0 |
| 30 Jun 19 | 0 | -3 | 1 | 0 |
Quality Earnings: EMD is currently unprofitable.
Growing Profit Margin: EMD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EMD is unprofitable, and losses have increased over the past 5 years at a rate of 22.7% per year.
Accelerating Growth: Unable to compare EMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EMD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (26.6%).
Return on Equity
High ROE: EMD has a negative Return on Equity (-472.33%), as it is currently unprofitable.